Aisling Capital Management Lp Portfolio Stock Holdings
Aisling Capital Management Lp disclosed 13 stock positions valued at approximately $476.3 million in its latest SEC 13F filing. The largest holdings include BridgeBio Pharma Inc. (BBIO), Syndax Pharmaceuticals, Inc. (SNDX), and Monte Rosa Therapeutics Inc (GLUE). The filing reflects positions held as of March 31, 2026 and was filed on May 5, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 13
- Portfolio Value
- $476.3M
Holdings by Sector
Aisling Capital Management Lp Portfolio Holdings in Q1 2026
8 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| BridgeBio Pharma Inc. (BBIO) | BBIO | Healthcare | 79.35% | 5,089,611 | - | - | $377,954,513 |
| Syndax Pharmaceuticals, Inc. (SNDX) | SNDX | Healthcare | 6.46% | 1,316,806 | - | - | $30,760,588 |
| Monte Rosa Therapeutics Inc (GLUE) | GLUE | Healthcare | 5.37% | 1,555,664 | +83,333 | +5.66% | $25,590,673 |
| Compass Pathways Plc (CMPS) | CMPS | Healthcare | 1.66% | 1,432,336 | +233,918 | +19.52% | $7,920,818 |
| Scholar Rock Holding Corporation (SRRK) | SRRK | Healthcare | 0.80% | 77,031 | - | - | $3,786,844 |
| Biomea Fusion Inc (BMEA) | BMEA | Healthcare | 0.66% | 2,048,757 | - | - | $3,134,598 |
| Aclaris Therapeutics Inc (ACRS) | ACRS | Healthcare | 0.34% | 434,455 | - | - | $1,629,206 |
| Marker Therapeutics, Inc. (MRKR) | MRKR | Healthcare | 0.09% | 325,370 | - | - | $422,981 |